Applovin Corporation Other Income (Expense) increased by 61.1% to -$8.53M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 81.2%, from -$45.38M to -$8.53M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 17.7% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$20.60M | -$27.97M | -$29.91M | -$30.00M | -$35.99M | -$47.66M | -$43.75M | -$64.40M | -$35.53M | -$77.09M | -$93.79M | -$71.61M | -$66.55M | -$66.57M | -$93.61M | -$45.38M | -$73.68M | -$58.06M | -$21.89M | -$8.53M |
| QoQ Change | — | -35.8% | -6.9% | -0.3% | -20.0% | -32.4% | +8.2% | -47.2% | +44.8% | -117.0% | -21.7% | +23.6% | +7.1% | -0.0% | -40.6% | +51.5% | -62.4% | +21.2% | +62.3% | +61.1% |
| YoY Change | — | — | — | — | -74.7% | -70.4% | -46.2% | -114.7% | +1.3% | -61.8% | -114.4% | -11.2% | -87.3% | +13.6% | +0.2% | +36.6% | -10.7% | +12.8% | +76.6% | +81.2% |